# Pfizer Limited reported a 40 percent year-on-year decline in net profit to ₹199.8 crore in Q4 FY26.

*biotech · news · 2026-05-12 · Free Press Journal*

## Key points

- Pfizer Limited's Q4 FY26 net profit fell 40% year-on-year to ₹199.8 crore.
- Sequential net profit rose 41% from Q3 FY26, aided by lower exceptional charges and reduced expenses.
- Pfizer incurred exceptional charges of ₹49.2 crore in FY26 due to personnel separation costs tied to Cipla.
- Employee benefits expense dropped to ₹77.2 crore in Q4 FY26 from ₹82.9 crore last year.
- Pfizer's board recommended a final dividend of ₹75 per equity share, totaling ₹343.1 crore.

**Companies:** Pfizer Limited, Cipla Limited
**Countries:** India

[Read the full story on Free Press Journal](https://www.freepressjournal.in/business/pfizer-q4-profit-falls-40-to-1998-crore-despite-revenue-growth-declares-75-dividend)

---

Canonical: https://newsio.io/n/79a74d76-15f8-456a-95c3-ccd556e0c271/pfizer-limited-reported-a-40-percent-year-on-year-decline-in-net-profit-to-199-8
Summarized by Newsio from Free Press Journal. https://newsio.io/how-it-works